These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24915209)

  • 1. Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
    Popiel KY; Miller MA
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):818-25. PubMed ID: 24915209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation.
    Bryce E; Grant J; Scharf S; Dempster L; Lau TT; Laing F; Shajari S; Forrester L
    Am J Infect Control; 2015 Nov; 43(11):1238-43. PubMed ID: 26190379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of discontinuing single-room isolation of patients with vancomycin-resistant enterococci: a quasi-experimental single-centre study in South Korea.
    Park S; Bae S; Kim EO; Chang E; Kim MJ; Chong YP; Choi SH; Lee SO; Kim YS; Jung J; Kim SH
    J Hosp Infect; 2024 May; 147():77-82. PubMed ID: 38492645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of Systematic Surveillance and Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) and Its Impact on the Incidence of VRE faecium Bacteremia in Patients with Hematologic Malignancies.
    Almyroudis NG; Osawa R; Samonis G; Wetzler M; Wang ES; McCarthy PL; Segal BH
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):398-403. PubMed ID: 26750087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients.
    Gandra S; Barysauskas CM; Mack DA; Barton B; Finberg R; Ellison RT
    J Hosp Infect; 2014 Nov; 88(3):170-6. PubMed ID: 25441487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions.
    Lai KK; Kelley AL; Melvin ZS; Belliveau PP; Fontecchio SA
    Infect Control Hosp Epidemiol; 1998 Sep; 19(9):647-52. PubMed ID: 9778162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Tool for the Prediction of Vancomycin-Resistant Enterococci Colonization Persistence-the PREVENT Score.
    Boeing C; Correa-Martinez CL; Schuler F; Mellmann A; Karch A; Kampmeier S
    Microbiol Spectr; 2021 Oct; 9(2):e0035621. PubMed ID: 34523992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience].
    Benzer D; Yavuzcan Öztürk D; Gürsoy T; Ocalmaz MS; Karatekin G; Ovalı HF
    Mikrobiyol Bul; 2012 Oct; 46(4):682-8. PubMed ID: 23188582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting.
    Frakking FNJ; Bril WS; Sinnige JC; Klooster JEV; de Jong BAW; van Hannen EJ; Tersmette M
    J Hosp Infect; 2018 Dec; 100(4):e216-e225. PubMed ID: 29475013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of vancomycin-resistant
    Cho SY; Kim HM; Chung DR; Choi JR; Lee MA; Huh HJ; Lee NY; Huh K; Kang CI; Peck KR
    Infect Control Hosp Epidemiol; 2022 May; 43(5):603-608. PubMed ID: 33993892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
    Johnstone J; Shing E; Saedi A; Adomako K; Li Y; Brown KA; Garber G
    Clin Infect Dis; 2020 Oct; 71(7):1756-1759. PubMed ID: 31922536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of discontinuing isolation in a private room for patients infected or colonized with vancomycin-resistant enterococci (VRE) on the incidence of healthcare-associated VRE bacteraemia in a hospital with a predominantly shared-room setting.
    Chang E; Im D; Lee HY; Lee M; Lee CM; Kang CK; Park WB; Kim NJ; Choe PG; Oh M
    J Hosp Infect; 2023 Feb; 132():1-7. PubMed ID: 36473555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients.
    Salgado CD
    Am J Infect Control; 2008 Dec; 36(10):S175.e5-8. PubMed ID: 19084155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysis.
    Mac S; Fitzpatrick T; Johnstone J; Sander B
    Antimicrob Resist Infect Control; 2019; 8():168. PubMed ID: 31687132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPIDEMIOLOGY AND CONTROL OF THE FIRST REPORTED VANCOMYCIN-RESISTANT ENTEROCOCCUS OUTBREAK AT A TERTIARY-CARE HOSPITAL IN BANGKOK, THAILAND.
    Chotiprasitsakul D; Santanirand P; Thitichai P; Rotjanapan P; Watcharananan S; Siriarayapon P; Chaihongsa N; Sirichot S; Chitasombat M; Chantharit P; Malathum K
    Southeast Asian J Trop Med Public Health; 2016 May; 47(3):494-502. PubMed ID: 27405133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong.
    Cheng VC; Tai JW; Chen JH; So SY; Ng WC; Hung IF; Leung SS; Wong SC; Chan TC; Chan FH; Ho PL; Yuen KY
    J Formos Med Assoc; 2014 Oct; 113(10):734-41. PubMed ID: 24796821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococcus (VRE) transmission and risk factors in contacts of VRE carriers.
    Kaki R; Yu Y; O'Neill C; Lee C; Mertz D;
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):876-9. PubMed ID: 24915218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.